Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10,094 | 7,768 | 0 | 0 | 0 |
| Cost of Goods | 7,765 | 4,741 | N/A | N/A | N/A |
| Gross Profit | 2,329 | 3,027 | N/A | N/A | N/A |
| Operating Expenses | 139,795 | 122,148 | 112,091 | 92,312 | 50,511 |
| Operating Income | -136,701 | -118,380 | -112,091 | -92,312 | -50,511 |
| Other Income | 6,665 | 1,722 | 1,873 | 25 | 48 |
| Pre-tax Income | -130,036 | -116,658 | -110,218 | -92,287 | -50,463 |
| Net Income Continuous | -130,036 | -116,658 | -110,218 | -92,287 | -50,463 |
| Net Income | $-130,036 | $-116,658 | $-110,218 | $-92,287 | $-50,463 |
| EPS Basic Total Ops | -176.60 | -14,720.25 | -63,929.71 | -161,741.20 | -0.55 |
| EPS Basic Continuous Ops | -176.60 | -14,720.25 | -60,282.02 | -161,832.90 | -0.53 |
| EPS Diluted Total Ops | -176.60 | -14,720.25 | -63,929.71 | -161,741.20 | -0.55 |
| EPS Diluted Continuous Ops | -176.60 | -14,720.25 | -60,282.02 | -161,832.90 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -176.60 | -21,884.98 | -65,295.53 | -165,868.80 | -350,876.31 |
| EBITDA(a) | $-132,440 | $-114,089 | $-110,838 | $-92,262 | $-50,484 |